Anika Therapeutics, Inc. (ANIK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Anika Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -12.67x | -4.30x | -4.02x | -29.01x | 124.82x | -26.84x |
| P/B Ratio | 0.96x | 1.57x | 1.56x | 1.51x | 1.80x | 2.36x |
| P/S Ratio | 1.22x | 2.02x | 2.75x | 3.79x | 3.49x | 4.93x |
| Profitability | ||||||
| Gross Margin | 56.6% | 63.4% | 68.3% | 64.3% | 56.1% | 52.9% |
| Operating Margin | -9.8% | -4.3% | 0.7% | 3.2% | 1.8% | -21.7% |
| Net Margin | -9.6% | -47.0% | -68.4% | -13.1% | 2.8% | -18.4% |
| EBITDA Margin | -4.7% | 2.5% | 12.5% | 16.0% | -2.8% | -0.8% |
| Liquidity | ||||||
| Current Ratio | 4.72x | 4.88x | 5.26x | 6.07x | 5.66x | 4.81x |
| Quick Ratio | 3.86x | 3.85x | 4.47x | 4.65x | 4.45x | 3.56x |
| Leverage | ||||||
| Debt/Equity | 0.17x | 0.17x | 0.13x | 0.11x | 0.07x | 0.08x |
YoY = year-over-year change. Source: FMP..